Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PM060184 |
| Synonyms | |
| Therapy Description |
Plocabulin (PM060184) is an anti-tubulin, which also binds to the minor groove of DNA, which may cause delayed progression through S-phase, premature cell cycle arrest, and cell death (PMID: 24486569, PMID: 32711367). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PM060184 | Plocabulin | PM-060184|PM 060184 | Plocabulin (PM060184) is an anti-tubulin, which also binds to the minor groove of DNA, which may cause delayed progression through S-phase, premature cell cycle arrest, and cell death (PMID: 24486569, PMID: 32711367). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01299636 | Phase I | PM060184 | Study of PM060184 in Patients With Advanced Solid Tumors | Completed | USA | 0 |